SynthesisClinical infectious diseases : an official publication of the Infectious Diseases Society of America2025
A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Complicated Urinary Tract Infections.
Synthesis in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Comparing Patient and Clinician Perceptions of Health-Related Quality of Life in Urinary Tract Infections.JAMA network open · 2026Article
- Patient-Reported Outcomes and Health-Related Quality-of-Life Measures in Infectious Diseases Studies and Clinical Practice.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundComplicated urinary tract infections (cUTIs) significantly affect patients' health-related quality of life (HRQoL), yet current end points defined by the United States Food and Drug Administration for antibiotic registrational trials fail to capture important elements of the patient experience with cUTI. In this systematic review, we aimed to identify measurement tools for HRQoL that have been studied in patients with cUTIs.
methodsFollowing a prospectively registered protocol in PROSPERO (CRD42020215641), English-language articles were queried using MEDLINE (via PubMed), Embase (Elsevier), and CINAHL (EBSCO) from database inception to 12 October 2022.
resultsWe identified 24 articles (96% rated as high quality) with 22 distinct measures. Overall, 45% of measures were categorized as generic and 27% as condition-specific; 27% were developed by researchers. Qualitative studies provided details regarding patient experience across multiple HRQoL domains.
conclusionsOur results add to the limited literature on HRQoL measures studied in cUTI and emphasize the importance of standardization, development, and validation of instruments to incorporate patients' voices into novel trial end points for cUTI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.